Alliancebernstein L.P. Morphic Holding, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 150,558 shares of MORF stock, worth $8.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,558

Previous 111,782 34.69%

Holding current value

$8.58 Million

Previous $3.93 Million 30.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.12 - $34.07 $1.01 Million - $1.32 Million	38,776 Added 34.69%	150,558 $5.13 Million
Q1 2024 May 14, 2024	SELL	$26.64 - $40.31 $2.59 Million - $3.93 Million	-97,394 Reduced 46.56%	111,782 $3.93 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $3.34 Million - $5.2 Million	167,606 Added 403.19%	209,176 $6.04 Million
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $23.9 Million - $66.5 Million	-1,119,047 Reduced 96.42%	41,570 $952,000
Q2 2023 Aug 15, 2023	BUY	$34.33 - $62.11 $37.7 Million - $68.1 Million	1,096,832 Added 1719.58%	1,160,617 $66.5 Million
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $102,661 - $192,179	-3,947 Reduced 5.83%	63,785 $2.4 Million
Q4 2022 Feb 14, 2023	BUY	$24.14 - $30.37 $380,277 - $478,418	15,753 Added 30.31%	67,732 $1.81 Million
Q3 2022 Nov 15, 2022	SELL	$22.23 - $33.37 $752,774 - $1.13 Million	-33,863 Reduced 39.45%	51,979 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $803,575 - $1.75 Million	40,708 Added 90.19%	85,842 $1.86 Million
Q1 2022 May 13, 2022	BUY	$36.25 - $52.02 $813,232 - $1.17 Million	22,434 Added 98.83%	45,134 $1.81 Million
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $25,962 - $39,432	-600 Reduced 2.58%	22,700 $1.08 Million
Q2 2021 Jul 30, 2021	BUY	$45.13 - $64.99 $437,761 - $630,403	9,700 Added 71.32%	23,300 $1.34 Million
Q1 2021 May 06, 2021	SELL	$29.77 - $84.85 $107,172 - $305,460	-3,600 Reduced 20.93%	13,600 $861,000
Q4 2020 Feb 08, 2021	SELL	$25.66 - $34.55 $2,566 - $3,454	-100 Reduced 0.58%	17,200 $577,000
Q3 2020 Nov 12, 2020	SELL	$22.51 - $30.11 $24,761 - $33,121	-1,100 Reduced 5.98%	17,300 $473,000
Q2 2020 Aug 13, 2020	BUY	$12.65 - $29.57 $99,935 - $233,603	7,900 Added 75.24%	18,400 $498,000
Q1 2020 May 14, 2020	BUY	$10.84 - $20.85 $113,820 - $218,925	10,500 New	10,500 $154,000

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Morphic Holding, Inc. Transaction History